Literature DB >> 17143888

Tandem duplication of DMD exon 18 associated with epilepsy, macroglossia, and endocrinologic abnormalities.

Claudia Weiss1, Sibylle Jakubiczka, Angela Huebner, Eva Klopocki, Wolfram Kress, Thomas Voit, Christoph Hübner, Markus Schuelke.   

Abstract

We describe a patient with Duchenne muscular dystrophy (DMD) who additionally suffered from intractable seizures, severe mental retardation, and a marked macroglossia. He also had endocrinologic abnormalities consisting of growth hormone deficiency, delayed puberty, and adrenal hypoplasia. We detected a duplication of DMD exon 18 and flanking introns that caused a frame-shift and was not removed by corrective splicing. A coincident mutation in the FKRP gene was excluded by direct sequencing. Complex DNA rearrangements, deletions, and duplications >100 kb were excluded through microarray-comparative genomic hybridization (CGH), although we were not able to exclude a second coincident mutation with certainty. In conclusion, we present a case of DMD that conflicts with current understanding of genotype-phenotype relations and discuss putative pathogenetic mechanisms for this uncommon phenotype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17143888     DOI: 10.1002/mus.20705

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  3 in total

1.  Ubiquitous internal gene duplication and intron creation in eukaryotes.

Authors:  Xiang Gao; Michael Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-19       Impact factor: 11.205

2.  Catheter ablation of multiple accessory pathways in duchenne muscular dystrophy.

Authors:  Josef Finsterer; Claudia Stöllberger; Christine Steger; Edmund Gatterer
Journal:  Korean Circ J       Date:  2013-02-28       Impact factor: 3.243

3.  Macroglossia associated with 271 bp deletion in exon 50 of dystrophin gene.

Authors:  Hardeep Singh Malhotra; Ratish Juyal; Kiran Preet Malhotra; Rakesh Shukla
Journal:  Ann Indian Acad Neurol       Date:  2011-01       Impact factor: 1.383

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.